Sign in
4

Changes in Ownership

FATE THERAPEUTICS INC Filed Acc 0001104659-23-130203

Director bought 44,630 shares at $3.72 ($166,024)

  • Director disposed of 1,655,370 shares (other)
  • Director acquired 1,655,370 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Redmile Group, LLC Director 2023-12-26 Other disposition −1,655,370 $3.72 $6,157,976 13,135,758 I
Redmile Group, LLC Director 2023-12-26 Other acquisition +1,655,370 $3.72 $6,157,976 13,135,758 I
Redmile Group, LLC Director 2023-12-26 Purchase +44,630 $3.72 $166,024 13,180,388 I
Open-market purchases · 44,630 sh · avg $3.72 · $166,024
Loading xslF345X05/tm2333829-2_4seq1.xml…